KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Cash from Financing Activities (2016 - 2025)

Amgen (AMGN) has 17 years of Cash from Financing Activities data on record, last reported at -$1.2 billion in Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 12.86% year-over-year to -$1.2 billion; the TTM value through Dec 2025 reached -$10.9 billion, down 15.34%, while the annual FY2025 figure was -$10.9 billion, 15.34% down from the prior year.
  • Cash from Financing Activities reached -$1.2 billion in Q4 2025 per AMGN's latest filing, up from -$2.9 billion in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $21.5 billion in Q1 2023 and bottomed at -$6.6 billion in Q4 2021.
  • Average Cash from Financing Activities over 5 years is -$576.7 million, with a median of -$1.8 billion recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: crashed 663.39% in 2021, then skyrocketed 712.09% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at -$6.6 billion in 2021, then skyrocketed by 84.0% to -$1.0 billion in 2022, then skyrocketed by 362.54% to $2.8 billion in 2023, then crashed by 151.09% to -$1.4 billion in 2024, then grew by 12.86% to -$1.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$1.2 billion in Q4 2025, -$2.9 billion in Q3 2025, and -$2.7 billion in Q2 2025.